Skip to main content

Clover Health Investments Corp (CLOV)

Financial Services Financial
Stock AI

Financial Metrics

Price to Earnings-131.33x
Revenue Growth (1Y)54.03%
Debt to Equity0x

Strengths

Stock Chart

Valuation

Clover Health Investments Corp is overvalued

News

All
Press Releases
News
Filings
10-Q Quarterly Report for 2026 Q2
August 07, 202610-Q Quarterly Report for 2026 Q2
Clover Health Reports Second Quarter 2026 Results
August 05, 2026Clover Health Reports Second Quarter 2026 Results
Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
July 22, 2026Clover Health to Participate in Upcoming Canaccord Genuity 46th Annual Growth Conference
Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
July 09, 2026Clover Health to Report Second Quarter 2026 Financial Results on August 5, 2026
Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
July 07, 2026Clinical Excellence in Continuity of Care: Counterpart Assistant (CA) Use Associated With Stronger Performance Across Transitions of Care Measures and Post-Hospitalization Follow-Up
Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
June 11, 2026Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating
10-Q Quarterly Report for 2026 Q1
May 08, 202610-Q Quarterly Report for 2026 Q1
Clover Health Reports First Quarter 2026 Results
May 06, 2026Clover Health Reports First Quarter 2026 Results
Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
April 08, 2026Clover Health to Report First Quarter 2026 Financial Results on May 6, 2026
Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
April 07, 2026Clover Health Empowers Members to Take Charge of Their Health Data Through HealthEx Partnership
Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
April 01, 2026Clover Health Announces Departure of Chief Financial Officer and Appointment of Interim Chief Financial Officer; Reiterates Most Recently Issued Financial Guidance for Full Fiscal Year 2026
Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
March 19, 2026Primary Care Physician Use of Counterpart Assistant Associated with 18%–22% Fewer Flu-Related Acute Care Events Among COPD and CHF Patients
UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
March 10, 2026UPDATED – Moving from Pledge to Production, Clover Health is Now Live on Kno2, Participating in Recently Announced Federal Interoperability Initiatives
Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
March 04, 2026Clover Health Moves from Pledge to Production, Becomes The First Payer Live on a CMS Aligned Network
10-K Annual Report for 2025 FY
February 27, 202610-K Annual Report for 2025 FY
Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
February 26, 2026Clover Health Reports Fourth Quarter & Full Year 2025 Results; Provides Full Year 2026 Guidance
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
February 17, 2026Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
January 29, 2026Clover Health to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November
January 14, 2026Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
January 14, 2026Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
January 12, 2026Counterpart Health 2025 Results: How Better Clinical Decisions at Scale Improve Outcomes, Quality, and Cost
Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
December 16, 2025Clover Health to Participate in Upcoming J.P. Morgan 2026 Healthcare Conference
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
November 17, 2025Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
10-Q Quarterly Report for 2025 Q3
November 07, 202510-Q Quarterly Report for 2025 Q3
Clover Health Reports Third Quarter 2025 Results
November 04, 2025Clover Health Reports Third Quarter 2025 Results
Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
October 31, 2025Clover Health Announces Chelsea Clinton to Step Down from Board Following Eight Years of Service
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
October 30, 2025Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
October 22, 2025Clover Health to Participate in Upcoming 2025 UBS Global Healthcare Conference
Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
October 15, 2025Clover Health’s 2026 Medicare Advantage Plans Champion Affordability and Choice
Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
October 14, 2025Counterpart Health Expands Proven Flywheel for HEDIS Excellence to Third-Party Partners
Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
October 09, 2025Clover Health Comments on 2026 Medicare Advantage Star Ratings and Trajectory for Increasing Profitability into 2027
Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
October 07, 2025Clover Health to Report Third Quarter 2025 Financial Results on November 4, 2025
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
October 06, 2025Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC
October 02, 2025SPAC King Chamath Palihapitiya Tells Retail Investors To Stay Away From His New SPAC
Counterpart Assistant Gets Conversational
September 25, 2025Counterpart Assistant Gets Conversational
Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
September 18, 2025Clover Health Celebrates the Election of Dr. Ian Duncan, Clover MA Board Member, as the 2025-2026 President-Elect and Vice-Chair of the Society of Actuaries
Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
September 16, 2025Clover Health Launches New Portal Availity® Essentials™ to Empower Providers and Improve the Patient Experience
Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
August 19, 2025Chamath Palihapitiya Returns To SPACs: Past 18 Deals, Investments Average Loss Of 14%
'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, Defense
August 19, 2025'SPAC King' Chamath Palihapitiya Returns With $250 Million 'American Exceptionalism' Deal Targeting AI, Energy, Defense
10-Q Quarterly Report for 2025 Q2
August 08, 202510-Q Quarterly Report for 2025 Q2
Clover Beats Q2 Estimates, Stock Drops: Here Are The Details
August 05, 2025Clover Beats Q2 Estimates, Stock Drops: Here Are The Details
What's Going On With Clover Health Stock?
July 08, 2025What's Going On With Clover Health Stock?
Clover Health (CLOV) Stock Soars This Week On Q1 Profitability, Up 320% Over Past Year
May 09, 2025Clover Health (CLOV) Stock Soars This Week On Q1 Profitability, Up 320% Over Past Year
10-Q Quarterly Report for 2025 Q1
May 09, 202510-Q Quarterly Report for 2025 Q1
10-K Annual Report for 2024 FY
March 03, 202510-K Annual Report for 2024 FY
Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
February 28, 2025Nvidia, Tesla Lead Tech Stock Rebound: What's Driving Markets Friday?
Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
February 27, 2025Trump's Tariffs, Potential 'Stagflation': What's Driving Markets Thursday?
Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
January 22, 2025Jim Cramer: AMD Is A 'Great' Company, Hold Onto Dow Inc.
10-Q Quarterly Report for 2024 Q3
November 08, 202410-Q Quarterly Report for 2024 Q3
10-Q Quarterly Report for 2024 Q2
August 08, 202410-Q Quarterly Report for 2024 Q2
10-Q Quarterly Report for 2024 Q1
May 07, 202410-Q Quarterly Report for 2024 Q1
10-K Annual Report for 2023 FY
March 14, 202410-K Annual Report for 2023 FY
10-Q Quarterly Report for 2023 Q3
November 06, 202310-Q Quarterly Report for 2023 Q3
10-Q Quarterly Report for 2023 Q2
August 08, 202310-Q Quarterly Report for 2023 Q2
10-Q Quarterly Report for 2023 Q1
May 09, 202310-Q Quarterly Report for 2023 Q1
10-K Annual Report for 2022 FY
March 01, 202310-K Annual Report for 2022 FY
10-Q Quarterly Report for 2022 Q3
November 07, 202210-Q Quarterly Report for 2022 Q3
10-Q Quarterly Report for 2022 Q2
August 08, 202210-Q Quarterly Report for 2022 Q2
10-Q Quarterly Report for 2022 Q1
May 09, 202210-Q Quarterly Report for 2022 Q1
10-K Annual Report for 2021 FY
February 28, 202210-K Annual Report for 2021 FY
10-Q Quarterly Report for 2021 Q3
November 09, 202110-Q Quarterly Report for 2021 Q3

A. Company Overview

Clover Health Investments Corp. is a healthcare company focused on improving healthcare delivery for Medicare beneficiaries through the integration of technology and healthcare services. The firm operates a unique business model that empowers healthcare providers to identify and manage chronic diseases early, thereby enhancing the quality of care and reducing overall costs. Clover Health was established on October 18, 2019, as a special purpose acquisition company and completed its initial public offering on April 24, 2020. It underwent a business combination with Clover Health Investments, Corp., officially changing its name and continuing under its current structure.

The company is headquartered in Franklin, Tennessee, and operates primarily in the United States, focusing on Medicare Advantage plans and expanding into non-insurance segments. Clover Health emphasizes its commitment to underserved markets, providing tailored healthcare solutions to diverse populations with varying socioeconomic backgrounds.

B. Business Model and Strategy

Clover Health’s business model is two-pronged, encompassing an Insurance segment and a Non-Insurance segment.

Insurance Segment

In its Insurance segment, Clover Health offers Medicare Advantage (MA) plans, including Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) options. These plans are designed to provide affordable, high-quality healthcare with attractive low co-payments and deductibles for primary care providers and specialists. The company is dedicated to ensuring a broad physician network, encouraging provider choice for its members, and promoting better healthcare access, particularly in underserved communities.

Clover Health aims to differentiate itself in the competitive Medicare Advantage market by leveraging its proprietary software platform, Clover Assistant, which provides physicians with data-driven insights. These insights enable enhanced clinical decision-making and are informed by a robust closed feedback loop that continuously refines the efficacy of the platform based on real-world use cases.

Non-Insurance Segment

Clover Health has expanded its services into the Non-Insurance segment by making Clover Assistant available through the Centers for Medicare & Medicaid Services (CMS) under the Accountable Care Organization (ACO) REACH model. The company recognizes the importance of home-based care management through programs like Clover Home Care, tailored for high-risk patients with complex medical needs. This initiative underscores Clover Health’s goal of integrating technology into healthcare delivery, making services more scalable and efficient.

C. Technology Platform: Clover Assistant

Clover Assistant is at the core of Clover Health’s strategy. It is a purpose-built technology platform designed to synthesize vast and varied data inputs, generating actionable insights to help healthcare providers enhance patient care. The platform integrates claims data, electronic health records, and other medical information, allowing healthcare providers to obtain comprehensive insights on their patients.

Key Features of Clover Assistant

  1. Data Utilization: Clover Assistant aggregates millions of data points daily, enabling practitioners to make informed decisions informed by evidence-based guidelines.
  2. Enhanced Provider Experience: Clover Assistant features a user-centric design that integrates smoothly with existing healthcare workflows, including systems like Epic and Cerner, enhancing usability for providers.
  3. Real-Time Intelligence: The platform employs advanced machine learning and artificial intelligence to provide real-time recommendations to adjusting treatment plans or updating care protocols based on the most current data.
  4. Continuous Improvement: Advanced analytics facilitate a rapid learn-iterate-deploy cycle, enabling Clover Assistant's algorithms to evolve based on user interaction and outcomes, maintaining a focus on improving clinical care capabilities.
  5. Actionable Insights for Chronic Disease Management: By offering real-time insights into chronic disease trajectories, the platform aids providers in identifying gaps in care and encouraging appropriate preventive measures.

D. Market Reach and Growth Opportunities

With an evolving healthcare landscape, Clover Health perceives vast opportunities within the growing Medicare demographic. By serving approximately 66 million Medicare beneficiaries in the U.S., including a substantial portion of underserved populations, the company is well-positioned to address critical gaps in healthcare delivery.

Regarding Medicare Advantage, the market is expected to grow significantly, culminating in projected annual expenditures of approximately $892 billion by 2030. Clover Health’s strategic approach focuses on targeting underserved markets where traditional managed care has struggled to establish service frameworks.

E. Clinical Programs

Alongside its technological advancements, Clover Health operates several clinical programs designed to bolster healthcare delivery for its members. Some notable programs include:

  1. Clover Home Care: A home-based care initiative that addresses the needs of complex patients with significant health burdens.
  2. Readmission Prevention Program: Aimed at minimizing hospital readmissions by providing care transition support to recently discharged patients.
  3. Behavioral Health Program: This comprehensive care coordination caters to patients with behavioral health needs, assisting with social services as necessary.
  4. Supportive Care Services: Advanced care planning and palliative care for individuals with limited life expectancy, ensuring humane and professional care.

F. Competitive Landscape

Clover Health operates in a highly competitive environment, facing both traditional insurance players such as UnitedHealth and Aetna, as well as innovative tech-driven startups focused on physician enablement. The healthcare technology sector’s rapid evolution introduces constant challenges related to maintaining a competitive edge through innovation and technology.

The company leverages its unique value proposition, predominantly driven by the Clover Assistant platform, empowering healthcare providers while improving clinical practices and plan performance.

G. Intellectual Property and Research Development

Intellectual property plays a crucial role in sustaining Clover Health’s competitive advantage. By maintaining a portfolio of patents and trade secrets applicable to Clover Assistant and other proprietary technologies, the company seeks to safeguard its innovations against competition and unauthorized usage.

Research and development efforts are concentrated on enhancing Clover Assistant's functionalities and ensuring it meets the evolving needs of healthcare providers and patients alike.

H. Regulatory Environment

Given its operations in the healthcare space, Clover Health is subject to comprehensive regulation at both state and federal levels. Regulatory oversight occurs primarily through the Centers for Medicare & Medicaid Services (CMS), which enforces standards, audits, and compliance with Medicare regulations. Compliance with regulations such as HIPAA for patient information protection and various anti-fraud laws is critically significant to the company’s operational integrity and reputation.

Stock Infos

SectorFinancial
IndustryFinancial Services
CEOAndrew Toy

Dividends

Copyright ©2026 Taurigo GmbH. All rights reserved.Taurigo GmbH provides no investment advice. Any analyses, research, ideas, prices, or other information contained on this website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice. We assume no responsibility for the accuracy, completeness or timeliness of any financial information contained on this site. In particular, we do not constitute an invitation to buy, sell or hold securities or other financial products. We shall not be liable for any loss or damage, including without limitation loss of profits, arising directly or indirectly from use of or reliance on the provided information. Before making any investment decision, you should consider whether it is suitable for your situation and obtain appropriate financial, tax and legal advice.